Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 166

The DOI matches its Crossref record.

Effects of Diltiazem or Lisinopril on Massive Proteinuria Associated with Diabetes Mellitus

Bakris, George L.·1990·Annals of Internal Medicine

Abstract

Brief Reports1 May 1990Effects of Diltiazem or Lisinopril on Massive Proteinuria Associated with Diabetes MellitusGeorge L. Bakris, MDGeorge L. Bakris, MDAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-112-9-707 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptRecent studies in hypertensive, diabetic rats have shown that angiotensin-converting enzyme inhibitors reduce urinary protein excretion and preserve renal function to a greater extent than other antihypertensive agents (1, 2). The effects of calcium channel antagonists on urinary protein excretion and renal hemodynamics vary (3, 4). The renal hemodynamic effects of diltiazem, however, have been shown to be similar to angiotensin-converting enzyme inhibitors (5, 6). We did a prospective crossover trial with diltiazem or lisinopril in eight diabetic, hypertensive patients with nephrotic-range proteinuria to compare the renal effects of these agents.Patients and MethodsEight noninsulin-dependent diabetic patients (three men...References1. AndersonRennkeGarciaBrenner SHDB. Short and long term effects of antihypertensive therapy in the diabetic rat. Kidney Int. 1989;36:526-36. CrossrefMedlineGoogle Scholar2. ZatzDunnMeyerAndersonRennkeBrenner RBTSHB. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest. 1986;77:1925-30. CrossrefMedlineGoogle Scholar3. JacksonCubelaDebreviWhittyJohnston BRLMC. Disparate effects of angiotensin converting enzyme inhibitor and calcium blocker treatment on the preservation of renal structure and function following subtotal nephrectomy or streptozotocin-induced diabetes in the rat. J Cardiovasc Pharmacol. 1987;10(Suppl 10):5167-9. Google Scholar4. MimranInsuaRibsteinMonnierBringerMirouse AAJLJJ Contrasting effects of Captopril and nifedipine in normotensive patients with incipient diabetic nephropathy. J Hypertens. 1988;6: 919-23. CrossrefMedlineGoogle Scholar5. IsshikiAmodeoMesserliPegramFrohlich TCFBE. Diltiazem maintains renal vasodilation without hyperfiltration in hypertension: studies in essential hypertensive man and spontaneously hypertensive rat Cardiovascular Drugs and Therapy. 1987;1:359-66. CrossrefMedlineGoogle Scholar6. AndersonClareyRileyTroy SLSJ. Acute infusion of calcium channel blockers reduces glomerular capillary pressure in rats with reduced renal mass [Abstract]. Kidney Int. 1988;33:370A. Google Scholar7. SunderrajanReamsBauer SGJ. Long-term renal effects of diltiazem in essential hypertension. Am Heart J. 1987;114:383-8. CrossrefMedlineGoogle Scholar8. GiorgiGiorgide Almeida BurdmannSilvaMarcoudes DMEHM. Effects of lisinopril on the renal plasma flow and renin-angiotensin-aldosterone system in patients with essential hypertension. J Hypertens. 1986;4(Suppl 5):5420-2. Google Scholar9. EisenbachLiewBoylanManzMuir GJJNP. Effect of angiotensin on the filtration of protein in the rat kidney: a micropuncture study. Kidney Int. 1975;8:80-7. CrossrefMedlineGoogle Scholar10. Heegde Jongvan der Hemde Zeeuw JPGD. Efficacy and variability of the antiproteinemic effect of ACE inhibition by lisinopril. Kidney Int. 1989;36:272-9. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: From the Ochsner Clinic, New Orleans, Louisiana. For current author address, see end of text. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByNondihydropyridine Calcium Channel Blockers for the Treatment of Proteinuria: A Review of the LiteratureCardiovascular Disease and Diabetic Kidney DiseaseTherapeutic Modalities in Diabetic Nephropathy: Standard and Emerging ApproachesTherapeutic Modalities in Diabetic Nephropathy: Future ApproachesDual therapy versus monotherapy of trandolapril and telmisartan on diabetic nephropathy in experimentally induced type 2 diabetes mellitus ratsJapan-Indonesia Collaborative Study of Imidapril on Antiproteinuric Effect in Hypertensive Patients with Chronic Kidney Disease (CKD)Effects of Calcium Channel Blockers on Proteinuria in Patients With Diabetic NephropathyAngiotensin receptor blockade in diabetic renal disease—Focus on candesartanChronic kidney disease (CKD) in the elderly – a geriatrician's perspectiveACE-inhibitor use and the long-term risk of renal failure in diabetesRenoprotective effect of diltiazem in hypertensive type 2 diabetic patients with persistent microalbuminuria despite ACE inhibitor treatmentBENEDICT in the treatment of hypertensionRenal Protection in Chronic Kidney DiseaseCalcium antagonistsNefroprotektivnyy effekt antigipertenzivnoy terapii: issledovanie IRISReferencesCALCIUM CHANNEL BLOCKERS IN THE PREVENTION OF END STAGE RENAL DISEASE: A REVIEWThe verapamil versus amlodipine in nondiabetic nephropathies treated with trandolapril (VVANNTT) studyComparative effec

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7326/0003-4819-112-9-707

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 166

Metadata

Authors
Bakris, G. L.
Venue
Annals of Internal Medicine
Published
1990-05-01
Volume
112
Issue
9
Pages
707-708
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W1996992946
Cited by
166
References
0
FWCI
23.86
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of Diltiazem or Lisinopril on Massive Proteinuria Associated with Diabetes Mellitus. https://app.cochat.ai/papers/10.7326/0003-4819-112-9-707
The paper
Bakris, G. L. (1990). Effects of Diltiazem or Lisinopril on Massive Proteinuria Associated with Diabetes Mellitus. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-112-9-707

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.